<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type='text/xml' href='//www.vaccineformulationinstitute.org/?wds_sitemap_styling=1&#038;template=sitemapBody'?><!-- SMARTCRAWL SITEMAP -->
<urlset
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	>
			<url>
<loc>https://www.vaccineformulationinstitute.org/</loc>
<lastmod>2025-04-04T12:29:28+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vfis-fight-against-coronavirus-during-2nd-wave-of-covid-pandemic/</loc>
<lastmod>2020-11-23T12:51:36+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/webinar-regulatory-information-for-veterinary-vaccine-development-in-the-eu-and-where-to-find-it/</loc>
<lastmod>2020-11-23T13:00:18+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vfi-presentation-at-biopole-workshops/</loc>
<lastmod>2020-11-23T13:02:39+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vfi-will-actively-support-the-development-of-vaccines-against-covid-19/</loc>
<lastmod>2020-11-23T13:48:47+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vfi-supports-sars-cov-2-vaccine-development-through-gh-vap-bill-melinda-gates-foundation/</loc>
<lastmod>2020-11-23T13:49:29+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vfi-supports-sars-cov-2-vaccine-development-through-transvac2-european-commission/</loc>
<lastmod>2020-11-23T13:49:56+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/6th-call-for-transvac-vaccine-development-services-tna/</loc>
<lastmod>2020-11-23T13:51:42+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/10th-call-for-transvac-vaccine-development-services-tna-deadline-15-december-2020/</loc>
<lastmod>2020-11-23T13:53:12+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vfi-supports-sars-cov-2-vaccine-development-through-transvac2-european-commission-copy/</loc>
<lastmod>2020-11-23T14:03:37+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/new-review-article-technological-approaches-for-improving-vaccination-compliance-and-coverage/</loc>
<lastmod>2020-11-23T14:03:59+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/new-review-article-modulation-of-immune-responses-using-adjuvants-to-facilitate-therapeutic-vaccination/</loc>
<lastmod>2020-11-23T14:04:14+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vfi-and-merck-provide-vaccine-process-development-training-courses-within-transvac2/</loc>
<lastmod>2020-11-24T13:14:40+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vidos-covid-19-vaccine-receives-health-canada-clinical-trial-approval/</loc>
<lastmod>2021-03-01T10:38:15+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/the-vaccine-formulation-institutes-squalene-in-water-adjuvant-swe-is-now-available-from-our-partner-seppic-under-the-name-sepivac-swe/</loc>
<lastmod>2021-03-01T10:38:24+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/4th-call-for-transvac-european-training-in-vaccinology-deadline-for-applications-1-june-2019-2/</loc>
<lastmod>2021-03-01T12:12:54+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/4th-call-for-transvac-european-training-in-vaccinology-deadline-for-applications-1-june-2019/</loc>
<lastmod>2021-03-01T12:13:34+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/start-of-covac-2-phase-1-clincial-trial/</loc>
<lastmod>2021-04-30T17:36:15+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/usasks-vido-announces-positive-phase-1-results-for-covac-2/</loc>
<lastmod>2021-06-28T14:03:54+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/isidore-integrated-services-for-infectious-disease-outbreak-research-officially-launched/</loc>
<lastmod>2022-03-14T09:11:41+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/cepi-awards-vido-and-vfi-for-covid-19-variants-vaccine-development/</loc>
<lastmod>2022-03-14T09:11:56+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vido-and-vfi-collaborate-to-strengthen-pandemic-preparedness/</loc>
<lastmod>2023-05-05T14:22:47+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/tbvac-horizon-a-boost-for-research-towards-a-better-understanding-of-local-lung-immunity-to-tuberculosis-infection/</loc>
<lastmod>2023-05-05T14:24:10+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/gvirf-webinar-vaccine-adjuvants-for-global-health/</loc>
<lastmod>2023-09-28T15:23:54+00:00</lastmod>
</url>			<url>
<loc>https://www.vaccineformulationinstitute.org/vfi-in-the-news/</loc>
<lastmod>2024-01-23T14:14:46+00:00</lastmod>
</url>	</urlset>